
Dimerix Limited (DXB) Receives a Buy from Petra Capital

I'm PortAI, I can summarize articles.
According to TipRanks, Jain is a 5-star analyst with an average return of 35.1% and a 45.95% success rate. Jain covers the Healthcare sector, focusing on stocks such as Pharmaust Limited, Argenica Therapeutics Ltd, and Dimerix Limited. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Dimerix Limited with a A$1.46 average price target.
According to TipRanks, Jain is a 5-star analyst with an average return of 35.1% and a 45.95% success rate. Jain covers the Healthcare sector, focusing on stocks such as Pharmaust Limited, Argenica Therapeutics Ltd, and Dimerix Limited.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Dimerix Limited with a A$1.46 average price target.

